Burapitant

DB20607ExperimentalSmall molecule

Burapitant is a small molecule drug. The usage of the INN stem '-pitant' in the name indicates that Burapitant is a neurokinin NK1 (substance P) receptor antagonist. Burapitant has a... Burapitant has a monoisotopic molecular weight of 681.2 Da.

Mechanism: Pharmacologically active on Substance-P receptor
Curator reviewed
Formula / weight: C₃₁H₃₅Cl₂F₆N₃O₃ · 682.53 g/mol (avg)
Code names: SSR-240600

Resolves to

Compound

UNIIE35SK332MSCAS537034-22-3

Structure

InChIKeyZLNYUCXXSDDIFU-LJAQVGFWSA-NSMILESCC(C)(C1CCN(CC[C@]2(CN(CCO2)C(=O)CC2=CC(=CC(=C2)C(F)(F)F)C(F)(F)F)C2=CC=C(Cl)C(Cl)=C2)CC1)C(N)=O

Targets

P25103TACR1

What you can answer from here — as of August 31, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Burapitant, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account